17 USD
+0.32 (+1.92%)
17 USD
0 (0%)
Taking everything into account, SLP scores 6 out of 10 in our fundamental rating. SLP was compared to 35 industry peers in the Health Care Technology industry. While SLP has a great health rating, its profitability is only average at the moment. SLP shows excellent growth, but is valued quite expensive already.
1. Profitability
1.1 Basic Checks
SLP had positive earnings in the past year.
In the past year SLP had a positive cash flow from operations.
In the past 5 years SLP has always been profitable.
Each year in the past 5 years SLP had a positive operating cash flow.
1.2 Ratios
The Return On Assets of SLP (-47.03%) is worse than 74.29% of its industry peers.
With a Return On Equity value of -51.05%, SLP perfoms like the industry average, outperforming 45.71% of the companies in the same industry.
SLP has a better Return On Invested Capital (3.12%) than 74.29% of its industry peers.
SLP had an Average Return On Invested Capital over the past 3 years of 4.57%. This is below the industry average of 6.67%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -47.03% | ||
| ROE | -51.05% | ||
| ROIC | 3.12% |
ROA(3y)5.68%
ROA(5y)5.6%
ROE(3y)6.11%
ROE(5y)6.04%
ROIC(3y)4.57%
ROIC(5y)5.03%
1.3 Margins
In the last couple of years the Profit Margin of SLP has declined.
SLP has a better Operating Margin (5.82%) than 68.57% of its industry peers.
SLP's Operating Margin has declined in the last couple of years.
SLP has a Gross Margin (53.75%) which is in line with its industry peers.
In the last couple of years the Gross Margin of SLP has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.82% | ||
| PM (TTM) | N/A | ||
| GM | 53.75% |
OM growth 3Y-28.77%
OM growth 5Y-22.51%
PM growth 3Y-12.26%
PM growth 5Y-10.86%
GM growth 3Y-7.23%
GM growth 5Y-3.44%
2. Health
2.1 Basic Checks
SLP has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
SLP has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, SLP has more shares outstanding
There is no outstanding debt for SLP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
SLP has an Altman-Z score of 20.14. This indicates that SLP is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 20.14, SLP belongs to the best of the industry, outperforming 91.43% of the companies in the same industry.
There is no outstanding debt for SLP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 20.14 |
ROIC/WACC0.31
WACC10.19%
2.3 Liquidity
A Current Ratio of 5.11 indicates that SLP has no problem at all paying its short term obligations.
With an excellent Current ratio value of 5.11, SLP belongs to the best of the industry, outperforming 88.57% of the companies in the same industry.
SLP has a Quick Ratio of 5.11. This indicates that SLP is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 5.11, SLP belongs to the best of the industry, outperforming 88.57% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.11 | ||
| Quick Ratio | 5.11 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 38.30% over the past year.
Measured over the past 5 years, SLP shows a small growth in Earnings Per Share. The EPS has been growing by 0.41% on average per year.
The Revenue has grown by 20.01% in the past year. This is a very strong growth!
Measured over the past years, SLP shows a quite strong growth in Revenue. The Revenue has been growing by 15.56% on average per year.
EPS 1Y (TTM)38.3%
EPS 3Y2.13%
EPS 5Y0.41%
EPS Q2Q%200%
Revenue 1Y (TTM)20.01%
Revenue growth 3Y14.64%
Revenue growth 5Y15.56%
Sales Q2Q%9.81%
3.2 Future
The Earnings Per Share is expected to grow by 21.41% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 9.40% on average over the next years. This is quite good.
EPS Next Y-764.23%
EPS Next 2Y-8.92%
EPS Next 3Y-1.05%
EPS Next 5Y21.41%
Revenue Next Year10.93%
Revenue Next 2Y6.11%
Revenue Next 3Y6.38%
Revenue Next 5Y9.4%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 26.15, which means the current valuation is very expensive for SLP.
Compared to the rest of the industry, the Price/Earnings ratio of SLP indicates a rather cheap valuation: SLP is cheaper than 82.86% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of SLP to the average of the S&P500 Index (25.47), we can say SLP is valued inline with the index average.
The Price/Forward Earnings ratio is 41.82, which means the current valuation is very expensive for SLP.
SLP's Price/Forward Earnings ratio is in line with the industry average.
SLP is valuated rather expensively when we compare the Price/Forward Earnings ratio to 34.42, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.15 | ||
| Fwd PE | 41.82 |
4.2 Price Multiples
SLP's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. SLP is cheaper than 68.57% of the companies in the same industry.
62.86% of the companies in the same industry are more expensive than SLP, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 32.44 | ||
| EV/EBITDA | 22.72 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)63.29
EPS Next 2Y-8.92%
EPS Next 3Y-1.05%
5. Dividend
5.1 Amount
SLP has a yearly dividend return of 0.61%, which is pretty low.
Compared to an average industry Dividend Yield of 4.65, SLP pays a better dividend. On top of this SLP pays more dividend than 94.29% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.41, SLP's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.61% |
5.2 History
The dividend of SLP has a limited annual growth rate of 0.01%.
SLP has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)0.01%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
SLP has negative earnings and hence a negative payout ratio. The dividend may be in danger.
SLP's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-1.9%
EPS Next 2Y-8.92%
EPS Next 3Y-1.05%
17
+0.32 (+1.92%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners86.07%
Inst Owner Change-5.99%
Ins Owners17.37%
Ins Owner Change-1.17%
Market Cap342.21M
Revenue(TTM)80.38M
Net Income(TTM)-63.19M
Analysts80
Price Target23.46 (38%)
Short Float %7.07%
Short Ratio2.24
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.61% |
Yearly Dividend0.24
Dividend Growth(5Y)0.01%
DP-1.9%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)160.9%
Min EPS beat(2)0.69%
Max EPS beat(2)321.12%
EPS beat(4)2
Avg EPS beat(4)55.29%
Min EPS beat(4)-90.66%
Max EPS beat(4)321.12%
EPS beat(8)3
Avg EPS beat(8)16.77%
EPS beat(12)4
Avg EPS beat(12)5.67%
EPS beat(16)7
Avg EPS beat(16)7.48%
Revenue beat(2)2
Avg Revenue beat(2)0.96%
Min Revenue beat(2)0.63%
Max Revenue beat(2)1.3%
Revenue beat(4)2
Avg Revenue beat(4)-1.21%
Min Revenue beat(4)-6.39%
Max Revenue beat(4)1.3%
Revenue beat(8)5
Avg Revenue beat(8)-0.3%
Revenue beat(12)6
Avg Revenue beat(12)-0.44%
Revenue beat(16)10
Avg Revenue beat(16)1.72%
PT rev (1m)-9.21%
PT rev (3m)-9.21%
EPS NQ rev (1m)16.67%
EPS NQ rev (3m)9.09%
EPS NY rev (1m)-30.57%
EPS NY rev (3m)-41.96%
Revenue NQ rev (1m)4.26%
Revenue NQ rev (3m)3.8%
Revenue NY rev (1m)0.9%
Revenue NY rev (3m)0.82%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.15 | ||
| Fwd PE | 41.82 | ||
| P/S | 4.26 | ||
| P/FCF | 32.44 | ||
| P/OCF | 24.09 | ||
| P/B | 2.76 | ||
| P/tB | 6.82 | ||
| EV/EBITDA | 22.72 |
EPS(TTM)0.65
EY3.82%
EPS(NY)0.41
Fwd EY2.39%
FCF(TTM)0.52
FCFY3.08%
OCF(TTM)0.71
OCFY4.15%
SpS3.99
BVpS6.15
TBVpS2.49
PEG (NY)N/A
PEG (5Y)63.29
Graham Number9.48
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -47.03% | ||
| ROE | -51.05% | ||
| ROCE | 3.77% | ||
| ROIC | 3.12% | ||
| ROICexc | 4.04% | ||
| ROICexgc | 17.48% | ||
| OM | 5.82% | ||
| PM (TTM) | N/A | ||
| GM | 53.75% | ||
| FCFM | 13.12% |
ROA(3y)5.68%
ROA(5y)5.6%
ROE(3y)6.11%
ROE(5y)6.04%
ROIC(3y)4.57%
ROIC(5y)5.03%
ROICexc(3y)12.97%
ROICexc(5y)16.03%
ROICexgc(3y)84.29%
ROICexgc(5y)97.41%
ROCE(3y)5.53%
ROCE(5y)6.08%
ROICexgc growth 3Y-24.94%
ROICexgc growth 5Y-20.15%
ROICexc growth 3Y-47.05%
ROICexc growth 5Y-36.7%
OM growth 3Y-28.77%
OM growth 5Y-22.51%
PM growth 3Y-12.26%
PM growth 5Y-10.86%
GM growth 3Y-7.23%
GM growth 5Y-3.44%
F-Score4
Asset Turnover0.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 40.33% | ||
| Cap/Sales | 4.55% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 103.33% | ||
| Profit Quality | N/A | ||
| Current Ratio | 5.11 | ||
| Quick Ratio | 5.11 | ||
| Altman-Z | 20.14 |
F-Score4
WACC10.19%
ROIC/WACC0.31
Cap/Depr(3y)99.44%
Cap/Depr(5y)102.61%
Cap/Sales(3y)6.89%
Cap/Sales(5y)7.35%
Profit Quality(3y)126.28%
Profit Quality(5y)123.52%
High Growth Momentum
Growth
EPS 1Y (TTM)38.3%
EPS 3Y2.13%
EPS 5Y0.41%
EPS Q2Q%200%
EPS Next Y-764.23%
EPS Next 2Y-8.92%
EPS Next 3Y-1.05%
EPS Next 5Y21.41%
Revenue 1Y (TTM)20.01%
Revenue growth 3Y14.64%
Revenue growth 5Y15.56%
Sales Q2Q%9.81%
Revenue Next Year10.93%
Revenue Next 2Y6.11%
Revenue Next 3Y6.38%
Revenue Next 5Y9.4%
EBIT growth 1Y-33.13%
EBIT growth 3Y-18.34%
EBIT growth 5Y-10.46%
EBIT Next Year145.07%
EBIT Next 3Y49.49%
EBIT Next 5Y49.82%
FCF growth 1Y-52.99%
FCF growth 3Y-14.87%
FCF growth 5Y-1.4%
OCF growth 1Y-46.86%
OCF growth 3Y-11.47%
OCF growth 5Y2.73%
SIMULATIONS PLUS INC / SLP FAQ
What is the ChartMill fundamental rating of SIMULATIONS PLUS INC (SLP) stock?
ChartMill assigns a fundamental rating of 6 / 10 to SLP.
What is the valuation status for SLP stock?
ChartMill assigns a valuation rating of 3 / 10 to SIMULATIONS PLUS INC (SLP). This can be considered as Overvalued.
How profitable is SIMULATIONS PLUS INC (SLP) stock?
SIMULATIONS PLUS INC (SLP) has a profitability rating of 4 / 10.
What are the PE and PB ratios of SIMULATIONS PLUS INC (SLP) stock?
The Price/Earnings (PE) ratio for SIMULATIONS PLUS INC (SLP) is 26.15 and the Price/Book (PB) ratio is 2.76.
Can you provide the dividend sustainability for SLP stock?
The dividend rating of SIMULATIONS PLUS INC (SLP) is 4 / 10 and the dividend payout ratio is -1.9%.